Rational and design of the REMOTE trial: An exploratory, pilot study to analyze REtinal MicrOcirculaTion in wEightlessness.

Microgravity dynamic vessel analyzer parabolic flight campaign retinal microcirculation spaceflight associated neuro-ocular syndrome

Journal

Clinical hemorheology and microcirculation
ISSN: 1875-8622
Titre abrégé: Clin Hemorheol Microcirc
Pays: Netherlands
ID NLM: 9709206

Informations de publication

Date de publication:
2023
Historique:
medline: 26 9 2023
pubmed: 24 1 2023
entrez: 23 1 2023
Statut: ppublish

Résumé

"Spaceflight associated neuro-ocular syndrome" (SANS) represents a challenging health condition in modern space medicine. Forty-eight percent of astronauts are diagnosed with SANS after long-term space missions. The pathophysiological mechanism seems to be multifactorial, and yet remains unknown. In this proof-of-concept study we plan to investigate retinal microcirculatory changes in weightlessness and aim to identify their role in the development of SANS. Healthy individuals will take part in a parabolic flight campaign, which recreates fractioned total weightlessness periods. The airplane is specifically equipped, and designed for the execution of parabolic flight maneuvers and scientific research in microgravity. Retinal microcirculation will be assessed with a modified fundus camera, which allows dynamic vessel analysis. We will additionally measure intra-ocular pressure and hemodynamic changes during each phase of the flight. Blood samples will be analyzed at baseline, one hour and 24 hours after exposure to weightlessness. This pilot study aims to investigate the feasibility of retinal microcirculation assessment during varying gravity. Results of this study may generate insights whether venous stasis in the eye, surrogated by the dilatation of retinal vessels and increase in intraocular pressure as signs of venous insufficiency, may potentially contribute to the development of SANS.

Sections du résumé

BACKGROUND BACKGROUND
"Spaceflight associated neuro-ocular syndrome" (SANS) represents a challenging health condition in modern space medicine. Forty-eight percent of astronauts are diagnosed with SANS after long-term space missions. The pathophysiological mechanism seems to be multifactorial, and yet remains unknown. In this proof-of-concept study we plan to investigate retinal microcirculatory changes in weightlessness and aim to identify their role in the development of SANS.
METHODS AND DESIGN METHODS
Healthy individuals will take part in a parabolic flight campaign, which recreates fractioned total weightlessness periods. The airplane is specifically equipped, and designed for the execution of parabolic flight maneuvers and scientific research in microgravity. Retinal microcirculation will be assessed with a modified fundus camera, which allows dynamic vessel analysis. We will additionally measure intra-ocular pressure and hemodynamic changes during each phase of the flight. Blood samples will be analyzed at baseline, one hour and 24 hours after exposure to weightlessness.
CONCLUSIONS CONCLUSIONS
This pilot study aims to investigate the feasibility of retinal microcirculation assessment during varying gravity. Results of this study may generate insights whether venous stasis in the eye, surrogated by the dilatation of retinal vessels and increase in intraocular pressure as signs of venous insufficiency, may potentially contribute to the development of SANS.

Identifiants

pubmed: 36683506
pii: CH221691
doi: 10.3233/CH-221691
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-457

Auteurs

Stephan Binneboessel (S)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Maryna Masyuk (M)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Kerstin Piayda (K)

Department of Cardiology and Vascular Medicine, Justus-Liebig-University Giessen, Medical Faculty, Giessen, Germany.

Raphael Romano Bruno (RR)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Bernhard Wernly (B)

Department of Anaesthesiology, Paracelsus Medical University Salzburg, Perioperative Medicine and Intensive Care Medicine, Salzburg, Austria.

Peter Jirak (P)

Department of Anaesthesiology, Paracelsus Medical University Salzburg, Perioperative Medicine and Intensive Care Medicine, Salzburg, Austria.

Georg Wolff (G)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Norbert Gerdes (N)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Philipp Heinrich Baldia (PH)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Malte Kelm (M)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Fabian Nienhaus (F)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Alexander Lang (A)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Holger Winkels (H)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for InternalMedicine, Cologne, Germany.

Gerd Geerling (G)

Department of Ophthalmology, Heinrich-Heine-University Duesseldorf, MedicalFaculty, Duesseldorf, Germany.

Rainer Guthoff (R)

Department of Ophthalmology, Heinrich-Heine-University Duesseldorf, MedicalFaculty, Duesseldorf, Germany.

Sema Kaya (S)

Department of Ophthalmology, Heinrich-Heine-University Duesseldorf, MedicalFaculty, Duesseldorf, Germany.

Gerald Flossmann (G)

iMEDOS Health GmbH, Jena, Germany.

Thomas Riemer (T)

iMEDOS Health GmbH, Jena, Germany.

Michael Baertschi (M)

Eyeness AG, Bern, Switzerland.

Christian Jung (C)

Department of Cardiology, Pulmonology, and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH